Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 7Phase 1/2 4Phase 3 2Phase NA 1

Status

Completed 255Unknown 172Active not recruiting 57Terminated 18Recruiting 15Withdrawn 3Suspended 3Not yet recruiting 2

Sponsor Class

OTHER 238INDUSTRY 113OTHER_GOV 12NETWORK 8NIH 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Specimen Handling 2ribociclib 1exemestane 1atezolizumab 1Watchful Waiting 1Observation 1Magnetic Resonance Spectroscopy 1Letrozole 1Hyaluronoglucosaminidase 1Drug Therapy 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × NIH × Clear all
NCT07388524 2026-05-13

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
336 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07391774 2026-05-13

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
1,978 enrolled
Breast

Anatomic Stage II Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡